GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » 3-D Matrix Ltd (TSE:7777) » Definitions » 10-Year Sharpe Ratio

3-D Matrix (TSE:7777) 10-Year Sharpe Ratio : -0.03 (As of Jul. 10, 2025)


View and export this data going back to 2011. Start your Free Trial

What is 3-D Matrix 10-Year Sharpe Ratio?

The 10-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past ten years. As of today (2025-07-10), 3-D Matrix's 10-Year Sharpe Ratio is -0.03.


Competitive Comparison of 3-D Matrix's 10-Year Sharpe Ratio

For the Medical Devices subindustry, 3-D Matrix's 10-Year Sharpe Ratio, along with its competitors' market caps and 10-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3-D Matrix's 10-Year Sharpe Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, 3-D Matrix's 10-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where 3-D Matrix's 10-Year Sharpe Ratio falls into.


;
;

3-D Matrix 10-Year Sharpe Ratio Calculation

The 10-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset in the last ten years. A stock / portfolio's 10-Year Sharpe Ratio can be calculated by dividing the difference between the ten-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the investment returns over the past ten years.


3-D Matrix  (TSE:7777) 10-Year Sharpe Ratio Explanation

The 10-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past ten years. It is calculated as the annualized result of the average ten-year monthly excess returns divided by its standard deviation in the ten-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


3-D Matrix 10-Year Sharpe Ratio Related Terms

Thank you for viewing the detailed overview of 3-D Matrix's 10-Year Sharpe Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


3-D Matrix Business Description

Traded in Other Exchanges
N/A
Address
3-2-4 Kojimachi, Chiyoda-ku, 7th floor, Kojimachi HF Building, Tokyo, JPN, 102-0083
3-D Matrix Ltd is engaged in the research, development, manufacture, and sale of medical devices based on the self-assembling peptide technology. Its products include PuraMatrix, High Concentration PuraMatrix, Modified Peptide and GMP Grade PuraMatrix.

3-D Matrix Headlines

No Headlines